NEW DELHI : India on Friday requested Bangladesh to begin early efficacy trials of Bharat Biotech’s anti-Covid vaccine which has been favourably received by Dhaka.The matter was raised during the India-Bangladesh Foreign Office Consultations held in New Delhi, Mint has learnt.
The Indian delegation was headed by Foreign Secretary Harsh Vardhan Shringla with his counterpart Masud Bin Momen leading the Bangladesh delegation.Also Read | Covid vaccination faces slow startBharat Biotech has developed Covaxin along with the New Delhi-based Indian Council of Medical Research.
It is one of two vaccines that Indian drug regulators have given the green signal to for inoculating Indians against Covid-19.